DaWon Kim, PhD

DaWon received her B.E. from Yonsei University and completed her Ph.D. in Pharmaceutical Sciences at the University of Wisconsin-Madison. For her graduate studies, she developed dendrimer-based nanoparticle platforms for targeted cancer immunotherapy and tumor biomarker detection. In the Corsello Lab, her research is focused on developing novel targeted protein degradation strategies for challenging cancer-associated proteins. She is excited to integrate chemical biology, cancer biology, and translational research to expand therapeutic strategies for cancer treatment.